News | March 18, 2022
AstraZeneca launches global R&D post-doctoral challenge
Successful proposals will secure fully funded postdoctoral research positions
Successful proposals will secure fully funded postdoctoral research positions
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
Subscribe To Our Newsletter & Stay Updated
